Insider Transactions in Q2 2023 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
George Poste Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+8.83%
|
-
|
|
Jun 01
2023
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+20.49%
|
-
|
|
Jun 01
2023
|
Jack L Wyszomierski Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+5.77%
|
-
|
|
Jun 01
2023
|
Jacqueline Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+28.59%
|
-
|
|
Jun 01
2023
|
Stelios Papadopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,718
+1.62%
|
-
|
|
May 31
2023
|
Tomas J. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,176
+50.0%
|
-
|
|
May 31
2023
|
Bob Oliver Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,176
+50.0%
|
-
|
|
May 31
2023
|
David Edward Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,176
+50.0%
|
-
|
|
May 15
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,967
-1.03%
|
$227,373
$19.18 P/Share
|
|
May 15
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,518
-5.22%
|
$636,842
$19.18 P/Share
|
|
May 15
2023
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,446
-1.58%
|
$350,474
$19.18 P/Share
|
|
May 15
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
10,488
-1.25%
|
$199,272
$19.18 P/Share
|
|
May 15
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
18,065
-1.83%
|
$343,235
$19.18 P/Share
|
|
Apr 05
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
38,930
-6.27%
|
$778,600
$20.01 P/Share
|
|
Apr 05
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,930
+2.19%
|
$195,020
$14.74 P/Share
|
|
Apr 03
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
79,719
+11.6%
|
-
|
|
Apr 03
2023
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
85,414
+12.64%
|
-
|
|
Apr 03
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
68,331
+14.0%
|
-
|
|
Apr 03
2023
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
313,185
+32.78%
|
-
|
|
Apr 03
2023
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
79,719
+19.34%
|
-
|
|
Apr 03
2023
|
Vicki L Goodman EVP, Prod Dev & Med Aff &CMO |
BUY
Grant, award, or other acquisition
|
Direct |
82,566
+21.16%
|
-
|